[go: up one dir, main page]

NO20083226L - Vannloselige filmer omfattende lavviskositet alginater - Google Patents

Vannloselige filmer omfattende lavviskositet alginater

Info

Publication number
NO20083226L
NO20083226L NO20083226A NO20083226A NO20083226L NO 20083226 L NO20083226 L NO 20083226L NO 20083226 A NO20083226 A NO 20083226A NO 20083226 A NO20083226 A NO 20083226A NO 20083226 L NO20083226 L NO 20083226L
Authority
NO
Norway
Prior art keywords
film
water
low viscosity
soluble films
viscosity alginates
Prior art date
Application number
NO20083226A
Other languages
English (en)
Other versions
NO343482B1 (no
Inventor
Kjell Stenberg
Fredrik Huebinette
Original Assignee
Fredrik Huebinette
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fredrik Huebinette filed Critical Fredrik Huebinette
Publication of NO20083226L publication Critical patent/NO20083226L/no
Publication of NO343482B1 publication Critical patent/NO343482B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Psychiatry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Det beskrives en film som omfatter, som et filmdannende middel, et alginatsalt av monovalent kation eller en blanding av alginatsalter inneholdende minst et alginatsalt av monovalent kation. Det filmdannende middelet er slik at en 10% vandig oppløsning derav ved en temperatur på 20?C har en viskositet på 100-1000 mPa s, som målt ved en skjærhastighet på 20 opm ved anvendelse av en Brookfield-viskosimeter med en spindel nr. 2. Det beskrives videre en fremgangsmåte for fremstilling av filmen. Filmen er anvendelig for levering av aktive bestanddeler til et pattedyr.
NO20083226A 2005-12-23 2008-07-22 Vannløselige filmer omfattende lavviskositet alginater NO343482B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0502900A SE530184C2 (sv) 2005-12-23 2005-12-23 Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
PCT/SE2006/050626 WO2007073346A1 (en) 2005-12-23 2006-12-22 Water-soluble films comprising low-viscosity alginates

Publications (2)

Publication Number Publication Date
NO20083226L true NO20083226L (no) 2008-09-18
NO343482B1 NO343482B1 (no) 2019-03-25

Family

ID=38188958

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083226A NO343482B1 (no) 2005-12-23 2008-07-22 Vannløselige filmer omfattende lavviskositet alginater

Country Status (25)

Country Link
US (1) US8759282B2 (no)
EP (2) EP3335732B1 (no)
JP (1) JP5425471B2 (no)
KR (2) KR20080080405A (no)
CN (1) CN101346154B (no)
AU (1) AU2006327277B2 (no)
BR (1) BRPI0620403B8 (no)
CA (1) CA2633878C (no)
CY (1) CY1120100T1 (no)
DK (1) DK1976562T3 (no)
ES (1) ES2664975T3 (no)
HR (1) HRP20180420T1 (no)
HU (1) HUE038619T2 (no)
IL (1) IL191994A (no)
LT (1) LT1976562T (no)
NO (1) NO343482B1 (no)
NZ (1) NZ569261A (no)
PL (1) PL1976562T3 (no)
PT (1) PT1976562T (no)
RS (1) RS57034B1 (no)
RU (1) RU2445977C2 (no)
SE (1) SE530184C2 (no)
SI (1) SI1976562T1 (no)
WO (1) WO2007073346A1 (no)
ZA (1) ZA200805287B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
SI2405942T1 (en) * 2009-03-13 2018-04-30 Excellent Tech Products I Sverige Ab Oral delivery product
EP4342456A3 (en) * 2009-04-03 2024-06-05 British American Tobacco Sweden AB Plant fiber product and method for its manufacture
WO2012137610A1 (ja) * 2011-04-08 2012-10-11 国立大学法人山梨大学 医薬製剤
ITTO20120258A1 (it) * 2012-03-21 2013-09-22 Fond Istituto Italiano Di Tecnologia Materiali compositi polimerici con proprieta' antimicrobiche e biodegradabili e loro usi.
US10799451B2 (en) 2012-03-27 2020-10-13 Nicoccino Ab Nicotine formulation
JP6412492B2 (ja) * 2012-03-27 2018-10-24 ニコチーノ・アクチボラグ ニコチン製剤
RU2525926C1 (ru) * 2013-01-09 2014-08-20 Мария Александровна Никулина Водорастворимая биодеградируемая съедобная упаковочная пленка
JP6001108B2 (ja) * 2015-02-02 2016-10-05 エクス−インターナショナル・エピエス 植物繊維製品およびその製造方法
JP2020500220A (ja) * 2016-11-15 2020-01-09 クラリア ファーマ ホールディング エービー 医薬製剤
GB201709141D0 (en) * 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
MX2020005890A (es) * 2017-12-20 2020-10-19 Klaria Pharma Holding Ab Formulacion de pelicula que comprende vardenafil, metodo para su preparacion y uso de la misma.
GB201807942D0 (en) * 2018-05-16 2018-06-27 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201808462D0 (en) * 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
CN108815141A (zh) * 2018-08-24 2018-11-16 中国农业科学院饲料研究所 抗菌肽膜剂及其制备方法与应用
CN113423290B (zh) * 2018-12-28 2023-08-04 菲利普莫里斯生产公司 包含金属盐的尼古丁制剂
US11877590B2 (en) 2019-03-27 2024-01-23 Fiedler & Lundgren Ab Smokeless tobacco composition
GB201911715D0 (en) * 2019-08-15 2019-10-02 Klaria Pharma Holding Ab Film formulation comprising carriers
WO2021090309A1 (en) * 2019-11-04 2021-05-14 Maabarot Products Ltd. Orally administrable films comprising poorly water soluble active ingredients and preparation thereof
CN119677760A (zh) * 2022-12-30 2025-03-21 西吉隆医疗股份有限公司 经修饰的多糖聚合物及其相关组合物和方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031200A (en) * 1975-12-15 1977-06-21 Hoffmann-La Roche Inc. Manufacture of pharmaceutical unit dosage forms
US4029758A (en) * 1975-12-15 1977-06-14 Hoffmann-La Roche Inc. Preparation of pharmaceutical unit dosage forms
US4029757A (en) * 1975-12-15 1977-06-14 Hoffmann-La Roche Inc. Manufacture of pharmaceutical unit dosage forms
US4713239A (en) * 1979-05-29 1987-12-15 Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr Antianginal film and method of treating ischemic heart disease
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US5229164A (en) * 1985-12-19 1993-07-20 Capsoid Pharma Gmbh Process for producing individually dosed administration forms
JPH0729915B2 (ja) * 1986-02-01 1995-04-05 帝國製薬株式会社 シ−ト状口腔内貼付剤
US4867970A (en) * 1987-05-21 1989-09-19 E. R. Squibb & Sons, Inc. Moistureless oral drug delivery formulation and method for preparing same
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4900552A (en) * 1988-03-30 1990-02-13 Watson Laboratories, Inc. Mucoadhesive buccal dosage forms
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
IT1248666B (it) * 1990-05-30 1995-01-26 Fidia Spa Gel in forma di film autosupportanti altamente idrati, processo per laloro preparazione e impiego nella terapia di lesioni e/o patologie cutanee
GB9016056D0 (en) 1990-07-21 1990-09-05 Chatfield Pharmaceuticals Limi Transdermal medicine delivery devices
SE466134B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5215758A (en) * 1991-09-11 1993-06-01 Euroceltique, S.A. Controlled release matrix suppository for pharmaceuticals
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
EP0717761A4 (en) * 1993-08-19 1998-01-07 Cygnus Therapeutic Systems WATER-SOLUBLE, PRESSURE-SENSITIVE AND MUCOADHESIVE ADHESIVE AND DEVICE FOR POSITIONING IT IN A MUCUTINE BODY CAVE
WO1995024172A1 (en) * 1994-03-07 1995-09-14 Theratech, Inc. Drug-containing adhesive composite transdermal delivery device
US5804209A (en) * 1994-06-16 1998-09-08 Pharmacia S.P.A. Bioadhesive starches and process for their preparation
WO1996000072A1 (en) * 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB2298365B (en) * 1995-03-03 1997-05-07 Reckitt & Colmann Prod Ltd A liquid pharmaceutical composition alginate and potassium bicarbonate
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
NO983911D0 (no) * 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US6419903B1 (en) * 2001-08-20 2002-07-16 Colgate Palmolive Company Breath freshening film
EP3542793A1 (en) 2001-10-12 2019-09-25 Aquestive Therapeutics, Inc. Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made therefrom
WO2003030883A1 (en) 2001-10-12 2003-04-17 Kosmos Pharma Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
NO20021592D0 (no) * 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
GB0210216D0 (en) 2002-05-03 2002-06-12 First Water Ltd Ionically crosslinked alginate hydrogels, process for their manufacture and their use in medical devices
GB0217382D0 (en) 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
US20040131661A1 (en) * 2002-07-26 2004-07-08 Pfizer Inc. Process for making orally consumable dosage forms
CA2504283A1 (en) 2002-10-31 2004-05-21 Umd, Inc. Therapeutic compositions for drug delivery to and through covering epithelia
US20040115137A1 (en) * 2002-12-17 2004-06-17 Verrall Andrew P. Water-soluble film for oral administration
KR20050096950A (ko) 2003-01-31 2005-10-06 오렉쏘 에이비 신속-작용 약학 조성물
GB2398496A (en) 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
JP2007528357A (ja) * 2003-04-14 2007-10-11 エフ　エム　シー　コーポレーション ゲルフィルムを製造するための方法
US20050013847A1 (en) * 2003-04-14 2005-01-20 Fmc Corporation Delivery systems of homogeneous, thermoreversible alginate films
US20050019294A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible alginate films and soft capsules made therefrom
US7243881B2 (en) * 2003-06-03 2007-07-17 The Boeing Company Multi-function trailing edge devices and associated methods
PL1740154T3 (pl) * 2004-03-12 2009-11-30 Biodel Inc Kompozycje insuliny o ulepszonym wchłanianiu

Also Published As

Publication number Publication date
WO2007073346A1 (en) 2007-06-28
HUE038619T2 (hu) 2018-10-29
RS57034B1 (sr) 2018-05-31
SE0502900L (sv) 2007-06-24
BRPI0620403A2 (pt) 2012-12-11
CY1120100T1 (el) 2018-12-12
PL1976562T3 (pl) 2018-06-29
RU2445977C2 (ru) 2012-03-27
KR101484530B1 (ko) 2015-01-20
SE530184C2 (sv) 2008-03-18
ES2664975T3 (es) 2018-04-24
BRPI0620403B8 (pt) 2021-05-25
BRPI0620403B1 (pt) 2020-11-10
CN101346154A (zh) 2009-01-14
JP2009521433A (ja) 2009-06-04
IL191994A0 (en) 2008-12-29
EP1976562B1 (en) 2018-02-21
EP1976562A4 (en) 2012-02-01
US8759282B2 (en) 2014-06-24
SI1976562T1 (en) 2018-06-29
DK1976562T3 (en) 2018-04-16
JP5425471B2 (ja) 2014-02-26
ZA200805287B (en) 2009-11-25
NZ569261A (en) 2012-08-31
LT1976562T (lt) 2018-05-25
HRP20180420T1 (hr) 2018-06-01
RU2008130391A (ru) 2010-01-27
CA2633878C (en) 2015-02-10
KR20140046488A (ko) 2014-04-18
US20090221489A1 (en) 2009-09-03
KR20080080405A (ko) 2008-09-03
EP1976562A1 (en) 2008-10-08
NO343482B1 (no) 2019-03-25
IL191994A (en) 2013-09-30
CN101346154B (zh) 2013-03-27
CA2633878A1 (en) 2007-06-28
AU2006327277A1 (en) 2007-06-28
AU2006327277B2 (en) 2012-12-13
PT1976562T (pt) 2018-04-09
EP3335732A1 (en) 2018-06-20
EP3335732B1 (en) 2020-10-14

Similar Documents

Publication Publication Date Title
NO20083226L (no) Vannloselige filmer omfattende lavviskositet alginater
UA116440C2 (uk) Композиція нікотину
BR112014009131A2 (pt) formulações de etanercept estabilizadas com meglumina
EP4311541A3 (en) Cryoprotective agents for particulate formulations
ES2609438T3 (es) Éteres de polisacáridos hidrófobamente modificados como potenciadores de la deposición para ingredientes agrícolamente activos
BR112017015032A2 (pt) composições curáveis e membranas
BRPI0900385A2 (pt) composições de tratamento de poço contendo salmouras de nitrato e método de usar as mesmas
RU2013120972A (ru) Гидроксид магния с высоким соотношением размеров кристаллов
BR112017018367A2 (pt) gelificação de éteres de celulose esterificados
CA3035124C (en) Polymorphic form of kinase inhibitor compound, pharmaceutical composition containing same, and preparation method therefor and use thereof
BR112018013985A2 (pt) glicosídeos de esteviol altamente solúveis
BR112018010861A2 (pt) massa de fundição e processo para fabricação de produtos de gelatina
BR112017019920A2 (pt) preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
BR112017005218A2 (pt) mistura de compostos, processo para fabricar uma mistura, formulação aquosa, e, uso de misturas de compostos.
BR112015016476A2 (pt) composição não aquosa para cuidados orais, composição para cuidados orais e processo de preparação de uma composição não aquosa
BRPI0811200A8 (pt) Tetra-hidrobenzapinas arilóxi- e heteroarilóxi-substituídas e uso das mesmas para bloquear percepção de norepinefrina, dopamina, e serotonina
AR074443A1 (es) Proceso para la preparacion de copolimeros con radicales al azar, y composiciones de sustancia activa que se pueden obtener a partir de ellos
WO2012021625A3 (en) Nonionic hydrophobically substituted cellulose ethers
ECSP066536A (es) Derivados de acidos fenoxiaceticos utiles como agonistas dobles dereceptor activado por proliferador de peroxisoma
BR112018005463A2 (pt) composição aquosa compreendendo éter de celulose esterificado disperso
MX2023004298A (es) Composiciones y métodos para almacenar fármacos oftálmicos estables.
BR112014018138A8 (pt) Composição de tratamento de superfície, meio de impressão e método para preparar uma composição de tratamento de superfície utilizada na fabricação de papel
BR112017028390A2 (pt) processo para preparação de um derivado de furfural
MX2020011130A (es) Forma de dosificacion solida que tiene excelente estabilidad.
PL434153A1 (pl) Kompozycja zawierająca kannabinoidy